» Articles » PMID: 29666412

Extensive T Cell Cross-reactivity Between Diverse Seasonal Influenza Strains in the Ferret Model

Overview
Journal Sci Rep
Specialty Science
Date 2018 Apr 19
PMID 29666412
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza virus causes widespread, yearly epidemics by accumulating surface protein mutations to escape neutralizing antibodies established from prior exposure. In contrast to antibody epitopes, T cell mediated immunity targets influenza epitopes that are more highly conserved and have potential for cross-protection. The extent of T cell cross-reactivity between a diverse array of contemporary and historical influenza strains was investigated in ferrets challenged with 2009 pandemic H1N1 influenza or the seasonal H3N2 strain, A/Perth/16/2009. Post-challenge cell-mediated immune responses demonstrated extensive cross-reactivity with a wide variety of contemporary and historical influenza A strains as well as influenza B. Responses in peripheral blood were undetectable by 36d post-challenge, but cross-reactivity persisted in spleen. The strongest responses targeted peptides from the NP protein and demonstrated cross-reactivity in both the CD4+ and CD8+ T cell populations. Cross-reactive CD4+ T cells also targeted HA and NA epitopes, while cross-reactive CD8+ T cells targeted internal M1, NS2, and PA. T cell epitopes demonstrated extensive cross-reactivity between diverse influenza strains in outbred animals, with NP implicated as a significant antigenic target demonstrating extensive cross-reactivity for both CD4+ and CD8+ T cells.

Citing Articles

Multi-strain modeling of influenza vaccine effectiveness in older adults and its dependence on antigenic distance.

Urdy S, Hanke M, Toledo A, Ratto N, Jacob E, Peyronnet E Sci Rep. 2024; 14(1):27190.

PMID: 39516205 PMC: 11549341. DOI: 10.1038/s41598-024-72716-1.


Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs.

Patil V, Hernandez-Franco J, Yadagiri G, Bugybayeva D, Dolatyabi S, Feliciano-Ruiz N Vaccines (Basel). 2023; 11(11).

PMID: 38006039 PMC: 10675483. DOI: 10.3390/vaccines11111707.


Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine.

Liu X, Zhao T, Wang L, Li M, Sun C, Shu Y Front Microbiol. 2022; 13:1014122.

PMID: 36246271 PMC: 9558277. DOI: 10.3389/fmicb.2022.1014122.


CD4 T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein.

Taborska P, Strizova Z, Stakheev D, Sojka L, Bartunkova J, Smrz D Front Immunol. 2021; 12:629102.

PMID: 34012431 PMC: 8128251. DOI: 10.3389/fimmu.2021.629102.


The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development.

Rioux M, Francis M, Swan C, Ge A, Kroeker A, Kelvin A Viruses. 2021; 13(4).

PMID: 33920917 PMC: 8071347. DOI: 10.3390/v13040678.


References
1.
Reber A, Kim J, Biber R, Talbot H, Coleman L, Chirkova T . Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses. Open Forum Infect Dis. 2015; 2(2):ofv052. PMC: 4567097. DOI: 10.1093/ofid/ofv052. View

2.
Wilkinson T, Li C, Chui C, Huang A, Perkins M, Liebner J . Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012; 18(2):274-80. DOI: 10.1038/nm.2612. View

3.
Tsuda Y, Weisend C, Martellaro C, Feldmann F, Haddock E . Pathogenic analysis of the pandemic 2009 H1N1 influenza A viruses in ferrets. J Vet Med Sci. 2017; 79(8):1453-1460. PMC: 5573836. DOI: 10.1292/jvms.16-0619. View

4.
Mak I, Evaniew N, Ghert M . Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014; 6(2):114-8. PMC: 3902221. View

5.
Thangavel R, Bouvier N . Animal models for influenza virus pathogenesis, transmission, and immunology. J Immunol Methods. 2014; 410:60-79. PMC: 4163064. DOI: 10.1016/j.jim.2014.03.023. View